
Astute Analytica
@AstuteAnalytic1
Followers
346
Following
2K
Media
956
Statuses
2K
At Astute Analytica, we strive to bring the best-in-class #Research services to our clients by creating unique and effective report insights.
India
Joined January 2021
The #multifunctional #printer #market is poised for robust growth, valued at US$39.9 billion in 2024 and projected to reach US$66.2 billion by 2033, with a steady CAGR of 5.8% from 2025 to 2033. This surge is driven by increasing demand for efficient, versatile printing solutions
0
0
2
The #Japan #processed #meat #market, valued at US$12.88 billion in 2024, is poised for significant growth, projected to reach US$20.27 billion by 2033, driven by a robust CAGR of 5.32% from 2025 to 2033. Rising consumer demand for convenient, high-quality protein sources, coupled
0
0
2
The #green #chemicals #market is poised for remarkable growth, valued at US$13.80 billion in 2024 and projected to reach US$28.05 billion by 2033, driven by a robust CAGR of 8.2% from 2025–2033. This surge reflects rising demand for sustainable, eco-friendly solutions across
0
0
2
RT @pulsarhelium: #PLSR UAV Expansion Puts Helium in Focus. The #UAV market is set to grow from US $66.3 BN in 2024 to $127 BN by 2033 - S….
0
3
0
Freedom’s flame #lights up our hearts and guides our future. Proud to celebrate the spirit of #India today and always. #Happy #IndependenceDay2025 from all of us at @AstuteAnalytic1 . #IndependenceDay #FreedomCelebration #ProudToBeIndian #VandeMataram #JaiHind
0
0
2
The global #AI #deception #tools #market was valued at US$ 680.12 million in 2024 and is projected to soar to US$ 6,361.7 million by 2033, growing at a remarkable CAGR of 28.20% during the forecast period 2025–2033. As cyber threats #become more advanced and persistent,
0
0
2
The #freeze-#drying #equipment #market is poised for robust growth, valued at US$3,031.67 million in 2024 and projected to reach US$5,087.49 million by 2033, driven by a steady CAGR of 5.71% from 2025 to 2033. This surge is fueled by increasing demand across pharmaceuticals,
0
0
2